Literature DB >> 22228041

Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice.

Hideaki Yamasawa1, Masayuki Nakayama, Masashi Bando, Yukihiko Sugiyama.   

Abstract

OBJECTIVE: To investigate the effect of hyperglycemic state on the activation of alveolar macrophages (AMs) mediated via Toll-like receptors (TLRs) typically associated with bacterial infection.
METHODS: AMs obtained from normoglycemic control mice and streptozotocin-induced diabetic mice were stimulated ex vivo with the following: a TLR2 ligand, peptidoglycan (PGN); a TLR4 ligand, lipopolysaccharide (LPS); or a TLR5 ligand, flagellin (FLG). Cytokine production and mRNA expression were measured by ELISA and real-time PCR, respectively. TLR expression was assessed by real-time PCR and flow cytometry.
RESULTS: AMs from diabetic mice produced significantly less TNF-α after PGN or FLG stimulation, and less IL-6 after FLG stimulation, compared with AMs from control mice. The decrease in the production of these cytokines was associated with reduced mRNA expression of the corresponding cytokines. In contrast, production of TNF-α and IL-6 after LPS stimulation did not differ between groups. Furthermore, there was no substantial difference in the expression of TLR2, TLR4, and TLR5 in AMs between the groups. The increased JNK phosphorylation induced by PGN or FLG stimulation was downregulated in AMs from diabetic mice.
CONCLUSIONS: Hyperglycemic state impairs the reactivity of AMs to multiple TLR ligands. This effect might result from hyperglycemia-induced alteration of intracellular signaling and is unlikely due to the modulation of TLR expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22228041     DOI: 10.1007/s00011-011-0426-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  45 in total

1.  Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.

Authors:  Mohammad K Mohammad; Michael Morran; Brandon Slotterbeck; Douglas W Leaman; Yaping Sun; Hermann von Grafenstein; Soon-Cheol Hong; Marcia F McInerney
Journal:  Int Immunol       Date:  2006-05-25       Impact factor: 4.823

2.  Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases.

Authors:  G E Salvi; J G Collins; B Yalda; R R Arnold; N P Lang; S Offenbacher
Journal:  J Clin Periodontol       Date:  1997-01       Impact factor: 8.728

3.  Role of Toll-like receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model.

Authors:  Etsu T Fuse; Kazuhiro Tateda; Yoshiaki Kikuchi; Tetsuya Matsumoto; Fumio Gondaira; Arata Azuma; Shoji Kudoh; Theodore J Standiford; Keizo Yamaguchi
Journal:  J Med Microbiol       Date:  2007-03       Impact factor: 2.472

4.  Impairment of endotoxin-induced macrophage inflammatory protein 2 gene expression in alveolar macrophages in streptozotocin-induced diabetes in mice.

Authors:  H Amano; H Yamamoto; M Senba; K Oishi; S Suzuki; K Fukushima; N Mukaida; K Matsushima; K Eguchi; T Nagatake
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Authors:  M T Schram; N Chaturvedi; C G Schalkwijk; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

6.  Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.

Authors:  Sylvia Knapp; Catharina W Wieland; Cornelis van 't Veer; Osamu Takeuchi; Shizuo Akira; Sandrine Florquin; Tom van der Poll
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Authors:  Frankie B Stentz; Guillermo E Umpierrez; Ruben Cuervo; Abbas E Kitabchi
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

8.  Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: a possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes.

Authors:  P H Lapchak; L J Guilbert; A Rabinovitch
Journal:  Clin Immunol Immunopathol       Date:  1992-11

9.  Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals.

Authors:  W Ptak; M Klimek; K Bryniarski; M Ptak; P Majcher
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  4 in total

Review 1.  O-GlcNAcylation and Inflammation: A Vast Territory to Explore.

Authors:  Léa Baudoin; Tarik Issad
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-09       Impact factor: 5.555

Review 2.  The Role of Innate Immunity in Pulmonary Infections.

Authors:  Huihui Zhang; Fang He; Pan Li; Philip R Hardwidge; Nengzhang Li; Yuanyi Peng
Journal:  Biomed Res Int       Date:  2021-01-22       Impact factor: 3.411

Review 3.  Respiratory Tract Infections in Diabetes - Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity.

Authors:  Amnah Al-Sayyar; Katina D Hulme; Ronan Thibaut; Jagadeesh Bayry; Frederick J Sheedy; Kirsty R Short; Fawaz Alzaid
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

Review 4.  Stress hyperglycemia, insulin treatment, and innate immune cells.

Authors:  Fangming Xiu; Mile Stanojcic; Li Diao; Marc G Jeschke
Journal:  Int J Endocrinol       Date:  2014-05-08       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.